Provectus Biopharmaceuticals, Inc.
PVCT- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000315545
No open-market purchases or sales by Provectus Biopharmaceuticals, Inc. insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $8.97K in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Provectus Biopharmaceuticals, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 7
- 0 vs. Q3 2022
- Shares held
- 226.3K
- −30.4K (−11.8%) vs. Q3 2022
- Total value
- $24.2K
- +$12.2K (+101.9%) vs. Q3 2022
- New holders
- 1
- 0 more added
- Sold out
- 1
- 1 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PVCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 4 | $8.97K |
| Q1 2026 | 6 | $10.4K |
| Q4 2025 | 5 | $10.2K |
| Q3 2025 | 7 | $20.4K |
| Q2 2025 | 7 | $17.1K |
| Q1 2025 | 7 | $22.9K |
| Q4 2024 | 6 | $21.2K |
| Q3 2024 | 7 | $22.3K |
| Q2 2024 | 7 | $28.6K |
| Q1 2024 | 6 | $32.7K |
| Q4 2023 | 7 | $21.9K |
| Q3 2023 | 6 | $18.2K |
| Q2 2023 | 7 | $26.0K |
| Q1 2023 | 7 | $36.8K |
| Q4 2022 | 7 | $24.2K |
| Q3 2022 | 7 | $12.0K |
| Q2 2022 | 7 | $17.0K |
| Q1 2022 | 7 | $176.0K |
| Q4 2021 | 7 | $146.0K |
| Q3 2021 | 8 | $16.0K |
| Q2 2021 | 7 | $16.0K |
| Q1 2021 | 8 | $16.0K |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Provectus Biopharmaceuticals, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Home Federal Bank of Tennessee | 100,000 | $10.8K | 0.00% | 00.0% | Unchanged |
| Lee Danner & Bass Inc | 50,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| Atlas Wealth LLC | 26,620 | $2.88K | 0.00% | +26,620 | New |
| LBMC Investment Advisors, LLC | 22,000 | $2.38K | 0.00% | 00.0% | Unchanged |
| Academy Capital Management Inc | 20,000 | $2.17K | 0.00% | 00.0% | Unchanged |
| Ancora Advisors, LLC | 7,650 | $1.00K | 0.00% | −7,000−47.8% | Reduced |
| Huntington National Bank | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Diversified Trust Co | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |